KUALA LUMPUR: The Alpha IVF Group Bhd (AIG) posted a net profit of RM13.58 million for the third quarter (Q3) ended February 29, 2024 (FY24).
Revenue stood at RM40.70 million for the quarter, attributed to the provision of assisted reproductive services, notably in-vitro fertilisation (IVF) treatments.
There are no previous earnings comparisons, as the company was listed on the ACE market of Bursa Malaysia on 22 March 2024.
In a filing with Bursa Malaysia, AIG did not provide any profit forecasts or guarantees for the current quarter.
AIG plans to grow and improve its operations using its IVF expertise.
The company plans to open more specialist centres in Malaysia, Indonesia, Cambodia, and Laos.
Further, the company plans to upgrade and expand current centres, facilities, and offices and launch marketing campaigns to promote services and attract customers locally and internationally.
In addition, AIG also plans to invest in research and development to stay ahead in assisted reproductive services and support business growth.
In the filing, AIG expresses optimism about its future in the assisted reproductive services field and the broader healthcare industry.
